[Studies on the combined effect of 6/N,N-hexyleneformamidine/-penicillanic acid (Preparation HX) and selected beta-lactam antibiotics on Escherichia coli and Salmonella. II. Studies in vivo].
D000560:Amdinocillin / Q000008:administration & dosage*; D000818:Animals; D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D002437:Cefazolin / Q000008:administration & dosage*; D002511:Cephalosporins / Q000008:administration & dosage*; D002515:Cephradine / Q000008:administration & dosage*; D004357:Drug Synergism; D004927:Escherichia coli Infections / Q000188:drug therapy*; D051379:Mice; D008807:Mice, Inbred BALB C; D010397:Penicillanic Acid / Q000008:administration & dosage*; D012480:Salmonella Infections / Q000188:drug therapy*
D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D010397:Penicillanic Acid; D002515:Cephradine; D002437:Cefazolin; D000560:Amdinocillin
Badania nad skojarzonym działaniem kwasu 6/N,N-1'6'-heksylenoformamidyno/-penicylanowego (preparatu HX) i wybranych antybiotyków beta-laktamowych wobec pałeczek E. coli i Salmonella. II. Badania in vivo.